Session 1
Title: Precision's Potential: Navigating Recent Advancements in Alzheimer's Diagnosis and Targeted Treatment
Presenter: James Rini, MD, MPH
Description: Precision's Potential: Navigating Recent Advancements in Alzheimer's Diagnosis and Targeted Treatment" is a comprehensive lecture by Dr. James Rini, exploring the cutting-edge in Alzheimer's diagnostics and the burgeoning field of individualized therapy. Dr. Rini, an Assistant Professor at the Ochsner Neuroscience Institute, will dissect the role of precision medicine in revolutionizing our approach to this pervasive neurodegenerative disorder. Attendees will delve into the latest biomarkers, the intricacies of Amyloid and Tau proteins, and the promise held by novel disease-modifying and symptomatic treatments. This presentation, free from commercial bias, offers an ethical and detailed map through the complexities of Alzheimer's research and its clinical implications.
Learning Objectives:
1.Understand the Impact of Precision Medicine: Gain a comprehensive understanding of how precision medicine is
currently shaping Alzheimer’s diagnostics, and what potential it has for future breakthroughs in the accurate identification and stratification of patients.
2. Explore Novel Diagnostic Biomarkers: Identify and explore the most recent advancements in neurocognitive biomarkers for Alzheimer's, including their applications in early detection, monitoring disease progression, and personalizing patient care.
3. Review Progress in Targeted Therapeutic Strategies: Review the latest developments in Alzheimer’s treatment,
including disease-modifying therapies and symptomatic treatments, with a focus on their mechanisms, efficacy,
and clinical applications.
4. Discuss Ethical Considerations and Clinical Implications: Engage with the ethical considerations inherent in the use of precision diagnostics and targeted treatments, and discuss the potential impact on patient care, healthcare resources, and clinical practices.
5. Evaluate the Use of Non-Invasive Biomarkers: Evaluate the current landscape of non-invasive commercially available neurodegenerative biomarkers for Alzheimer’s, discussing their validity, practicality, and integration into clinical workflows
Session 2
Presentation: Cognitive Rehabilitation in Pediatric Neurological Disorders: Evidence-Based and Clinical Applications
Presenter: Gianna Locascio, PsyD, ABPP
Description: Cognitive rehabilitation is broadly defined as a variety of systematic interventions designed to compensate for or ameliorate the impact of cognitive and/or behavioral difficulties following a neurologic injury or illness with the ultimate goals to maximize safety and improve daily functioning, independence, and quality of life. Interventions are typically and traditionally delivered by specialists in medical and rehabilitation settings, as well as in some educational settings. This course will review updates to the evidence-based literature on efficacy of cognitive rehabilitation for children and adolescents with acquired neurologic conditions including traumatic brain injuries, stroke, and brain tumors as well as neurodevelopmental conditions. Real-world strategies will be presented to effectively translate the evidence into clinical
practice with a focus on using cognitive rehabilitation in clinical and school settings.
Learning Objectives:
1. Describe the level of evidence for pediatric cognitive rehabilitation.
2. Summarize one specific evidence-based cognitive rehabilitation program.
3. Discuss strategies to effectively implement cognitive rehabilitation in educational settings.